BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 4401160)

  • 1. Effects of sympathetic and central nervous system alterations on the blood pressure responses to phentolamine.
    Hilliard CC; Bagwell EE; Daniell HB
    J Pharmacol Exp Ther; 1972 Mar; 180(3):743-7. PubMed ID: 4401160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrolinone hydrochloride (doxapram). 1. The action on the central nervous system].
    Kuga T; Naito J
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):701-10. PubMed ID: 4148712
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that phentolamine acts centrally to increase the contractile force of the heart.
    Hilliard CC; Bagwell EE; Daniell HB
    Eur J Pharmacol; 1972 May; 18(3):338-45. PubMed ID: 4624702
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ; Blickenstaff T; Gaffney TE; Mohammed S
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract]   [Full Text] [Related]  

  • 6. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the central nervous system in the cardiovascular responses to yohimbine.
    Lang WJ; Lambert GA; Rush ML
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):57-67. PubMed ID: 242288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of the pressor and tachycardiac effects of ketamine. 1. Effects of sympathetic nerve inhibition].
    Saito T; Wakisaka K; Hirano T
    Masui; 1971 Sep; 20(9):833-41. PubMed ID: 5166766
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of regitine on the frequency of plethysmographic alpha waves.
    Stancák A; Schweitzer R; Medvecká E
    Act Nerv Super (Praha); 1971; 13(3):205-6. PubMed ID: 4398845
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the sympathetic nervous system in the cardiovascular effects of cocaine.
    Gillis RA; Bachenheimer LC; Dretchen KL; Erzouki HK; Hernandez YM; Jain RK; Jain MK; Kuhn FE; Quest J; Schaer GL
    NIDA Res Monogr; 1991; 108():92-109. PubMed ID: 1749420
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac slowing effects of clonidine (ST-155) in dogs.
    Scriabine A; Stavorski J; Wenger HC; Torchiana ML; Stone CA
    J Pharmacol Exp Ther; 1970 Feb; 171(2):256-64. PubMed ID: 5272380
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of reserpine on the cardiovascular responses to phentolamine.
    Hilliard CC; Bagwell EE; Daniell HB; Freeman BF
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):55-63. PubMed ID: 5059369
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of the cardiovascular response to isoproterenol by pilocarpine.
    Daniell HB; Bagwell EE
    Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):141-52. PubMed ID: 5350777
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of sympathetic nerve system and skeletal muscles in theophylline-induced thermogenesis. Studies on non-shivering thermogenesis. 2 (author's transl)].
    Kurahashi M
    Nihon Seirigaku Zasshi; 1974; 36(2):62-71. PubMed ID: 4152719
    [No Abstract]   [Full Text] [Related]  

  • 15. The pressor effect of oxotremorine and arecoline in rats.
    Phan DV; György L
    Acta Physiol Acad Sci Hung; 1973; 43(1):71-84. PubMed ID: 4149154
    [No Abstract]   [Full Text] [Related]  

  • 16. Quinterenol, a new beta adrenergic stimulant.
    Scriabine A; Moore PF; Iorio LC; Goldman IM; McShane WK; Booher KD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):60-9. PubMed ID: 4385348
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of lidocaine, hexamethonium and alpha and beta adrenergic blocking agents on the pulmonary veins in intact dogs.
    Hyman AL
    J Pharmacol Exp Ther; 1970 Sep; 174(3):487-99. PubMed ID: 5456181
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular cholinergic receptor systems: interaction with adrenergic systems.
    Dempsey PJ; Cooper T
    J Pharmacol Exp Ther; 1969 Jun; 167(2):282-90. PubMed ID: 5787867
    [No Abstract]   [Full Text] [Related]  

  • 19. Venous responses to prostaglandin F2 alpha.
    Mark AL; Schmid PG; Eckstein JW; Wendling MG
    Am J Physiol; 1971 Jan; 220(1):222-6. PubMed ID: 4992254
    [No Abstract]   [Full Text] [Related]  

  • 20. Actions of bretylium tosylate on the cardiovascular system of the dog.
    Richmond DR; Angus JA; Goodman AH; Cobbin LB
    Cardiovasc Res; 1973 Jan; 7(1):47-54. PubMed ID: 4694956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.